Filing Flows › Charles River Laboratories International (CRL) › Who owns the stock
Who owns Charles River Laboratories International (CRL) stock
555 funds reported Charles River Laboratories International (CRL) shares in their latest 13F filings, worth $13.7B in all. The largest holder is Vanguard Group ($1.2B). Last quarter 241 funds added to their stakes and 237 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 5,887,175 | $1.2B | increase | 2025-12-31 |
| FMR LLC | 4,239,752 | $962M | increase | 2026-06-30 |
| BlackRock | 3,798,560 | $861M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 3,149,288 | $714M | decrease | 2026-06-30 |
| Invesco | 2,984,785 | $677M | increase | 2026-06-30 |
| Harris Associates L P | 2,241,144 | $508M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2,210,979 | $501M | decrease | 2026-06-30 |
| Allspring Global Investments Holdings, LLC | 1,905,247 | $436M | decrease | 2026-06-30 |
| State Street | 1,864,284 | $423M | decrease | 2026-06-30 |
| Dimensional Fund Advisors LP | 1,648,450 | $374M | decrease | 2026-06-30 |
| Ariel Investments, LLC | 1,506,185 | $342M | increase | 2026-06-30 |
| Price T Rowe Associates | 1,505,370 | $341M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 1,305,738 | $296M | increase | 2026-06-30 |
| Wellington Management Group LLP | 1,288,463 | $292M | decrease | 2026-06-30 |
| Citadel Advisors LLC | 1,193,601 | $271M | decrease | 2026-06-30 |
Charles River Laboratories International's latest quarter
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CRL stock?
By the latest 13F filings: Vanguard Group ($1.2B); FMR LLC ($962M); BlackRock ($861M); Vanguard Capital Management LLC ($714M); Invesco ($677M).
What is the short interest in CRL?
2,834,023 shares were sold short at the 2026-10-15 settlement, -1.55% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.